Legal Opinion
In Re Eli Lilly & Company
Court of Appeals for the Federal Circuit
Decided April 30, 1990No. 89-1076PublishedCited by 13 opinions
1Opinion of the Court
PAULINE NEWMAN, Circuit Judge.
The decision of the United States Patent and Trademark Office Board of Patent Appeals and Interferences (the “Board”), rejecting claims 1-7, all of the claims on reexamination of United States Patent No. 3,794,732, inventor Arthur P. Raun, assign-ee Eli Lilly & Company (hereinafter “Lilly”), is affirmed.
Background
The Raun claims are directed to the method of using the chemical compound identified as X537A (common name “lasalo-cid”) to enhance feed conversion efficiency in mature ruminant animals such as cattle and sheep.
Claim 1 of the Raun patent is illustrative:
1…
2Cases cited8 opinions
- In Re Patrick H. O'farrell, Barry A. Polisky and David H. GelfandCourt of Appeals for the Federal Circuit · 1988
- In Re Frank N. Piasecki and Donald N. MeyersCourt of Appeals for the Federal Circuit · 1984
- In re RinehartCourt of Customs and Patent Appeals · 1976
- In Re John P. ChuppCourt of Appeals for the Federal Circuit · 1987
- In re YatesCourt of Customs and Patent Appeals · 1981
3 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
- The Gillette Company v. S.C. Johnson & Son, Inc.Court of Appeals for the Federal Circuit · 1990
- Takeda Chemical Industries, Ltd. v. Mylan Laboratories, Inc.District Court, S.D. New York · 2006
- GRACEWAY PHARMACEUTICALS, LLC v. Perrigo Co.District Court, D. New Jersey · 2010
- W.R. Grace & Co.-Conn. v. Intercat, Inc.District Court, D. Delaware · 1997
8 more not listed; retrieve them via the Exa API.